RE:RE:RE:RE:RE:Good article on Tilray strategic planFeb 13, 2024 OGI reported: Organigram reports $15 million loss in part due to lower international revenue and medical sale https://stratcann.com/news/organigram-reported-a-net-loss-of-15m/
"Reintroduced its Edison Jolts to the market, with $2.9 million in sales in Q1 2024, which was previously removed from shelves following orders from Health Canada".
"Organigram continues to wait for EU-GMP certification of its Moncton facility".
Sounds like management